Skip to main content
. 2017 May 17;16(6):910–916. doi: 10.1177/1533034617709396

Table 2.

Dosimetric Comparison of the Targets Between the ART and Non-ART Plans.a

Parameters Non-ART ART P Value
PTVnx
 HI 1.12 (0.03) 1.11 (0.04) .076
 CI 0.94 (0.01) 0.97 (0.02) .045b
 Dmax (Gy) 78.12 (2.55) 77.15 (1.25) .034b
 Dmin(Gy) 63.42 (1.74) 64.30 (2.17) .219
 Dmean (Gy) 72.66 (72.38-73.55) 73.29 (72.31-73.74) .335
 D95 (Gy) 70.26 (1.07) 70.61 (1.17) .067
 D99 (Gy) 68.24 (1.05) 68.91 (1.57) .096
 V110 (%) 0.40 (0.00-1.99) 0.05 (0.00-0.23) .033b
 V100 (%) 94.77 (2.20) 96.01 (2.50) .104
 V95 (%) 99.81 (99.56-100.00) 99.94 (99.66-100.00) .011b
 V93 (%) 99.99 (99.89-100.00) 100.00 (99.94-100.00) .068
PTVnd
 HI 1.11 (0.01) 1.09 (0.03) .796
 CI 0.85 (0.05) 0.90 (0.01) .028b
 Dmax (Gy) 76.77 (2.29) 76.71 (1.37) .877
 Dmin (Gy) 44.31 (8.69) 47.38 (9.99) .191
 Dmean (Gy) 71.52 (1.61) 72.42 (1.57) .057
 D95 (Gy) 66.33 (2.85) 68.55 (1.91) .021b
 D99 (Gy) 58.90 (5.74) 63.43 (2.85) .031b
 V110(%) 0.00 (0.00-0.07) 0.07 (0.00-0.74) .807
 V100 (%) 86.25 (5.17) 91.78 (3.99) .038b
 V95 (%) 95.17 (2.08) 98.01 (1.78) .041b
 V93 (%) 96.11 (2.32) 98.48 (1.17) .038b
PTV1
 HI 1.28 (0.03) 1.27 (0.03) .178
 CI 0.98 (0.05) 0.99 (0.07) .019b
 Dmax (Gy) 77.50 (1.37) 77.12 (1.85) .208
 Dmin (Gy) 51.89 (6.95) 52.87 (6.15) .407
 Dmean (Gy) 70.36 (0.71) 70.66 (1.09) .285
 D95 (Gy) 63.71 (1.06) 64.21 (1.10) .219
 D99 (Gy) 60.16 (2.58) 61.09 (1.55) .037b
 V100 (%) 98.01 (1.14) 98.71 (0.97) .028b
 V95 (%) 99.51 (99.07-100.00) 99.78 (0.59) .291
 V93 (%) 99.23 (99.51-100.00) 99.74 (0.24) .185
PTV2
 HI 1.45 (0.07) 1.44 (0.09) .418
 CI 0.93 (0.07) 0.98 (0.01) .009b
 Dmax (Gy) 78.55 (1.84) 77.90 (1.47) .531
 Dmin (Gy) 28.17 (25.06-34.17) 28.44 (26.09-35.91) .882
 Dmean (Gy) 63.03 (2.55) 63.10 (1.98) .207
 D95 (Gy) 53.10 (1.13) 55.02 (1.07) .018b
 D99 (Gy) 49.11 (1.78) 50.58 (1.57) .029b
 V100 (%) 95.14 (1.55) 96.01 (1.17) .023b
 V95 (%) 97.62 (1.29) 98.07 (1.01) .030b
 V93 (%) 98.01 (0.24) 99.00 (0.18) .041b

Abbreviations: ART, adaptive radiation therapy; CI, conformity index; Dmax, maximum dose; Dmin, minimum dose; Dmean, mean dose; D95, dose to 95% of the volume; D99, dose to 99% of the volume; HI, homogeneity index; V93, percentage of the volume receiving more than 93% of the prescription dose; V95, percentage of the volume receiving more than 95% of the prescription dose; V100, percentage of the volume receiving more than 100% of the prescription dose; V110, percentage of the volume receiving more than 110% of the prescription dose.

aDifference was calculated by paired sample t test or Wilcoxon rank sum test according to data types. Mean (standard deviation) was used for data with normal distribution, whereas median (interquartile range) was used for data with skewed distribution.

bStatistical significance.